首页> 美国卫生研究院文献>Theranostics >Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms
【2h】

Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms

机译:使用电活性导电聚合物纳米线平台从癌症患者中有效捕获和分离肿瘤相关循环无细胞DNA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Circulating cell-free DNA (cfDNA) is currently recognized as a key non-invasive biomarker for cancer diagnosis and progression and therapeutic efficacy monitoring. Because cfDNA has been detected in patients with diverse types of cancers, the use of efficient strategies to isolate cfDNA not only provides valuable insights into tumour biology, but also offers the potential for developing new cancer-specific targets. However, the challenges associated with conventional cfDNA extraction methods prevent their further clinical applications. Here, we developed a nanostructured conductive polymer platform for the efficient capture and release of circulating cfDNA and demonstrated its potential clinical utility using unprocessed plasma samples from patients with breast and lung cancers. Our results confirmed that the platform's enhanced efficiency allows tumor-specific circulating cfDNA to be recovered at high yield and purity.
机译:循环无细胞DNA(cfDNA)当前被公认为是癌症诊断,进展和治疗效果监测的关键非侵入性生物标志物。由于已在患有多种癌症的患者中检测到cfDNA,因此使用有效策略分离cfDNA不仅为肿瘤生物学提供了有价值的见解,而且还为开发新的癌症特异性靶标提供了潜力。然而,与常规cfDNA提取方法相关的挑战阻止了其进一步的临床应用。在这里,我们开发了一种用于高效捕获和释放循环cfDNA的纳米结构导电聚合物平台,并使用来自乳腺癌和肺癌患者的未处理血浆样品证明了其潜在的临床实用性。我们的结果证实,该平台的效率提高,可使肿瘤特异性循环cfDNA以高产率和高纯度回收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号